# Actimus BioSciences Private Ltd. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/actimus-biosciences-private-ltd/f668409f-a167-4e1a-ac4f-9566691bf987

> Inspection records and compliance data for Actimus BioSciences Private Ltd. in Gajuwaka, None. Access full analysis and detailed observations.

---

## Details

- Name: Actimus BioSciences Private Ltd.
- FEI Number: 3007078752
- City: Gajuwaka
- State: None
- Country Name: India
- Address Line 1: D - 2 D Block Autonagar, D-Block Road
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1232136 - Actimus BioSciences Private Ltd. - 2024-02-02](https://www.globalkeysolutions.net/records/fda_inspections/actimus-biosciences-private-ltd/c6ad8b61-dc68-4ab0-ba4a-b9a3b3ffa941) — classification: No Action Indicated (NAI), source: FDA, date: February 2, 2024
- [FDA Inspection 1219736 - Actimus BioSciences Private Ltd. - 2023-09-22](https://www.globalkeysolutions.net/records/fda_inspections/actimus-biosciences-private-ltd/da81fc86-f24d-4419-8a61-1922c479a728) — classification: No Action Indicated (NAI), source: FDA, date: September 22, 2023
- [FDA Inspection 1177347 - Actimus BioSciences Private Ltd. - 2022-07-14](https://www.globalkeysolutions.net/records/fda_inspections/actimus-biosciences-private-ltd/825aa6eb-7200-46c4-8df6-5efd28f75a92) — classification: No Action Indicated (NAI), source: FDA, date: July 14, 2022
- [FDA Inspection 1087025 - Actimus BioSciences Private Ltd. - 2019-02-22](https://www.globalkeysolutions.net/records/fda_inspections/actimus-biosciences-private-ltd/d73bfa03-cff9-4d15-a1cc-bfb6495a964b) — classification: No Action Indicated (NAI), source: FDA, date: February 22, 2019

## Related Companies

- [Fougera Pharmaceuticals  Inc.](https://www.globalkeysolutions.net/companies/fougera-pharmaceuticals-inc/3868bd8e-22c5-4998-85b0-38e0df2d115b)
- [Particle Technology Group, LLC](https://www.globalkeysolutions.net/companies/particle-technology-group-llc/739b37e7-35ae-45aa-a515-a9d4d01fccb7)
- [Element Materials Technology Pharma USA LLC](https://www.globalkeysolutions.net/companies/element-materials-technology-pharma-usa-llc/d40408f6-37dd-44fb-8760-20aa927a8e8c)
- [QualTech Laboratories, Inc.](https://www.globalkeysolutions.net/companies/qualtech-laboratories-inc/7cf9f443-ef52-4807-8a49-2322da5f4133)
- [American Regent, Inc.](https://www.globalkeysolutions.net/companies/american-regent-inc/9e5e908d-150e-4cb7-9d39-ab0eef6c4c0e)
- [Eurofins Biolab S.r.l.](https://www.globalkeysolutions.net/companies/eurofins-biolab-srl/3f1b31b8-2af2-4083-8cdb-3e0fbf994b22)
- [R.D. Laboratories Inc.](https://www.globalkeysolutions.net/companies/rd-laboratories-inc/b75c7a7e-9454-4127-add6-6107232599f1)
- [Eurofins BioPharma Product Testing Columbia, LLC](https://www.globalkeysolutions.net/companies/eurofins-biopharma-product-testing-columbia-llc/b616a9a6-094c-4f02-80ba-59880916eaf2)
- [SGS Institut Fresenius GmbH](https://www.globalkeysolutions.net/companies/sgs-institut-fresenius-gmbh/9053e3ca-148d-4280-ac0d-789a34084eb8)
- [Quinta Analytica s.r.o.](https://www.globalkeysolutions.net/companies/quinta-analytica-sro/f26231ff-818d-4ba0-b952-72115b356982)